This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Day, C. Search for Related Content Social Bookmarking                         What's this?

The rising tide of type 2 diabetes

Diabetes Group, School of Pharmacy, Aston University, Birmingham, cday{at}mededuk.com Br

The number of people with diabetes is now considered to have reached epidemic proportions. Globally more the 150 million people have diabetes, accounting for more than 2% of the world's population and 3—5% of adults in most westernised societies. The incidence rates of type 1 and particularly type 2 diabetes are increasing in all societies and on all continents. Type 2 diabetes accounts for more than 95% of all diabetes. Type 2 diabetes is highly prevalent in the elderly and is now emerging in childhood. In developed countries diabetes and its complications constitute the fourth or fifth leading cause of death, and type 2 diabetes reduces remaining lifespan by 5—10 years. Diabetes (all types) is estimated to affect about 2.4 million people (prevalence of 4%) in the UK, of whom 1.4 million (prevalence of 2.5%) are diagnosed and one million undiagnosed. With the global prevalence of diabetes predicted to exceed 220 million by 2010 and 300 million by 2025 there is a major international challenge for optimal intervention and prevention strategies.

Key Words: epidemiology • age • ethnicity • gender • UK prevalence.

The British Journal of Diabetes & Vascular Disease, Vol. 1, No. 1, 37-43 (2001)
DOI: 10.1177/14746514010010010601


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. M Dodson Diabetic retinopathy: treatment and prevention Diabetes and Vascular Disease Research, September 1, 2007; 4(3_suppl): S9 - S11. [Abstract] [PDF]

				P. Barter Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: an Asian/Pacific consensus: The Pan-Asian Consensus Panel On Hdl-C The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2_suppl): S1 - S15. [Abstract] [PDF]

				M. G Buckley, S. N Liversedge, and J. D Dean Diabetes services in primary care: are we prepared for the diabetes NSF? The British Journal of Diabetes & Vascular Disease, November 1, 2003; 3(6): 418 - 423. [Abstract] [PDF]

				P. H Evans, M. Luthra, R. Powell, K. G Sweeney, and D. P. Gray Diagnosis of type 2 diabetes in primary care The British Journal of Diabetes & Vascular Disease, September 1, 2003; 3(5): 342 - 344. [Abstract] [PDF]

				C. A Reasner and B. Goke Overcoming the barriers to effective glycaemic control for type 2 diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 290 - 295. [PDF]

				K. Heald, T. Jay, and R. Downing Human islet transplantation: expectation versus reality The British Journal of Diabetes & Vascular Disease, November 1, 2001; 1(2): 128 - 130. [Abstract] [PDF]